Literature DB >> 15152006

Human immunodeficiency virus type 1 Gag assembly through assembly intermediates.

Yuko Morikawa1, Toshiyuki Goto, Fumitaka Momose.   

Abstract

Human immunodeficiency virus Gag protein self-assembles into spherical particles, and recent reports suggest the formation of assembly intermediates during the process. To understand the nature of such assembly intermediates along with the mechanism of Gag assembly, we employed expression in Escherichia coli and an in vitro assembly reaction. When E. coli expression was performed at 37 degrees C, Gag predominantly assembled to a high order of multimer, apparently equivalent to the virus-like particles obtained following Gag expression in eukaryotic cells, through the formation of low orders of multimer characterized with a discreet sedimentation value of 60 S. Electron microscopy confirmed the presence of spherical particles in the E. coli cells. In contrast, expression at 30 degrees C resulted in the production of only the 60 S form of Gag multimer, and crescent-shaped structures or small patches with double electron-dense layers were accumulated, but no complete particles. In vitro assembly reactions using purified Gag protein, when performed at 37 degrees C, also produced the high order of Gag multimers with some 60 S multimers, whereas the 30 degrees C reaction produced only the 60 S multimers. However, when the 60 S multimers were cross-linked so as not to allow conformational changes, in vitro assembly reactions at 37 degrees C did not produce any higher order of multimers. ATP depletion did not halt Gag assembly in the E. coli cells, and the addition of GroEL-GroES to in vitro reactions did not facilitate Gag assembly, indicating that conformational changes rather than protein refolding by chaperonins, induced at 37 degrees C, were solely responsible for the Gag assembly observed here. We suggest that Gag assembles to a capsid through the formation of the 60 S multimer, possibly a key intermediate of the assembly process, accompanied with conformational changes in Gag.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15152006     DOI: 10.1074/jbc.M313432200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  17 in total

1.  Production of human papillomavirus type 16 L1 virus-like particles by recombinant Lactobacillus casei cells.

Authors:  Karina Araujo Aires; Aurora Marques Cianciarullo; Sylvia Mendes Carneiro; Luisa Lina Villa; Enrique Boccardo; Gaspar Pérez-Martinez; Isabel Perez-Arellano; Maria Leonor Sarno Oliveira; Paulo Lee Ho
Journal:  Appl Environ Microbiol       Date:  2006-01       Impact factor: 4.792

2.  Intermolecular interactions between retroviral Gag proteins in the nucleus.

Authors:  Scott P Kenney; Timothy L Lochmann; Cullen L Schmid; Leslie J Parent
Journal:  J Virol       Date:  2007-10-31       Impact factor: 5.103

3.  Structures formed by the recombinant derivate of the gypsy retrovirus structural protein Gag in bacterial cells.

Authors:  B V Syomin; N A Kazilo; O G Leonova; Yu L Ivanova; Y V Ilyin; V I Popenko
Journal:  Dokl Biochem Biophys       Date:  2007 Nov-Dec       Impact factor: 0.788

4.  Quantitative fluorescence resonance energy transfer microscopy analysis of the human immunodeficiency virus type 1 Gag-Gag interaction: relative contributions of the CA and NC domains and membrane binding.

Authors:  Ian B Hogue; Adam Hoppe; Akira Ono
Journal:  J Virol       Date:  2009-04-29       Impact factor: 5.103

Review 5.  How HIV-1 Gag assembles in cells: Putting together pieces of the puzzle.

Authors:  Jaisri R Lingappa; Jonathan C Reed; Motoko Tanaka; Kasana Chutiraka; Bridget A Robinson
Journal:  Virus Res       Date:  2014-07-24       Impact factor: 3.303

6.  HIV Gag-leucine zipper chimeras form ABCE1-containing intermediates and RNase-resistant immature capsids similar to those formed by wild-type HIV-1 Gag.

Authors:  Kevin C Klein; Jonathan C Reed; Motoko Tanaka; Veronica T Nguyen; Samina Giri; Jaisri R Lingappa
Journal:  J Virol       Date:  2011-05-04       Impact factor: 5.103

7.  Distinct roles for nucleic acid in in vitro assembly of purified Mason-Pfizer monkey virus CANC proteins.

Authors:  Pavel Ulbrich; Sarka Haubova; Milan V Nermut; Eric Hunter; Michaela Rumlova; Tomas Ruml
Journal:  J Virol       Date:  2006-07       Impact factor: 5.103

Review 8.  Design of virus-based nanomaterials for medicine, biotechnology, and energy.

Authors:  Amy M Wen; Nicole F Steinmetz
Journal:  Chem Soc Rev       Date:  2016-07-25       Impact factor: 54.564

9.  Characterization of a myristoylated, monomeric HIV Gag protein.

Authors:  Jun Dou; Jaang-Jiun Wang; Xuemin Chen; Hua Li; Lingmei Ding; Paul Spearman
Journal:  Virology       Date:  2009-03-12       Impact factor: 3.616

10.  Characterization of the in vitro HIV-1 capsid assembly pathway.

Authors:  Eric Barklis; Ayna Alfadhli; Carolyn McQuaw; Suraj Yalamuri; Amelia Still; Robin Lid Barklis; Ben Kukull; Claudia S López
Journal:  J Mol Biol       Date:  2009-02-03       Impact factor: 5.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.